Capricorn Fund Managers Ltd

Position in JNJ — Johnson & Johnson

CIK 1901361 LONDON, X0

Position in JNJ

as of Jun 30, 2026 · filed Jul 24, 2026 Compact

Position Value

$431,749

-$6,384,290 QoQ

Shares Held

1,700

-95.4% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

#3,842

of 4,676 holders

Holding Since

Sep 2023

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Capricorn Fund Managers Ltd holds $34,667,354 across 6 Drug Manufacturers - General names. JNJ ranks #6 (1.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	GSK	GSK plc	426,416	$22,352,726
2	ABBV	AbbVie Inc.	27,397	$6,894,181
3	GILD	Gilead Sciences, Inc.	31,200	$3,941,808
4	PFE	Pfizer Inc	22,130	$532,890
5	MRK	Merck & Co., Inc.	4,000	$514,000
6	JNJ	Johnson & Johnson This page	1,700	$431,749

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$431,749	1,700	-95.4%	Shares	Sole	2026-07-24
2025-09-30	$6,816,039	36,760	-45.9%	Shares	Sole	2025-10-17
2025-03-31	$11,268,496	67,948	-0.9%	Shares	Sole	2025-05-08
2024-12-31	$9,913,701	68,550	+0.4%	Shares	Sole	2025-01-17
2024-09-30	$11,061,891	68,258	+26.6%	Shares	Sole	2024-10-11
2024-06-30	$7,880,654	53,918	+56.2%	Shares	Sole	2024-07-12
2024-03-31	$5,459,295	34,511	0.0%	Shares	Sole	2024-04-12
2023-12-31	$5,409,254	34,511	+229.9%	Shares	Sole	2024-01-10
2023-09-30	$1,629,300	10,461	—	Shares	Sole	2023-10-11
No filing history on record for this holder in this stock.